Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/06/2002 | EP1184349A1 Method for obtaining a surface activation of a solid support for building biochips microarrays |
03/06/2002 | EP1183541A1 Screening methods for altering circadian rhythm proteins |
03/06/2002 | EP1183536A1 Fluorescence polarisation assays involving polyions |
03/06/2002 | EP1183534A2 Identification of novel mechanisms of drug resistance |
03/06/2002 | EP1183521A1 Nucleic acid-based detection |
03/06/2002 | EP1183516A1 Platform for chemical or biological analysis with microbalances, analysis device and method using same |
03/06/2002 | EP1183393A1 Pcr-based identification of eimeria species and strains |
03/06/2002 | EP1183390A1 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY |
03/06/2002 | EP1183389A2 Adeno-associated virus-delivered ribozyme compositions and methods of use |
03/06/2002 | EP1183386A1 Tm4sf receptors |
03/06/2002 | EP1183385A1 Methods and materials for the synthesis of organic products |
03/06/2002 | EP1183384A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
03/06/2002 | EP1183383A1 Siv-based packaging-deficient vectors |
03/06/2002 | EP1183382A2 Method for selecting improved vectors |
03/06/2002 | EP1183381A2 Synthetic gene for expressing active retroviral protein in eukaryotes |
03/06/2002 | EP1183380A1 Compositions and methods useful for production of recombinant viruses which require helper viruses |
03/06/2002 | EP1183379A2 Promoter system and production and use of the same |
03/06/2002 | EP1183378A2 Nucleotide sequence for increasing the defense reaction of a plant against infection by a pathogen |
03/06/2002 | EP1183377A1 IMPROVED METHOD FOR i AGROBACTERIUM /i MEDIATED TRANSFORMATION OF COTTON |
03/06/2002 | EP1183376A1 Isoflavonoid methylation enzyme |
03/06/2002 | EP1183375A2 Tapetum-specific promoters |
03/06/2002 | EP1183374A1 Recombinant fusion protein, (vaccine) composition containing the same and method for the production thereof |
03/06/2002 | EP1183373A1 Polypeptides with protein disulfide reducing properties |
03/06/2002 | EP1183372A2 Mprot45 metalloprotease |
03/06/2002 | EP1183371A2 Composition designed for implementing an antitumoral or antiviral treatment in a mammal |
03/06/2002 | EP1183370A2 Human oxidoreductase proteins |
03/06/2002 | EP1183369A1 Polyketides and their synthesis |
03/06/2002 | EP1183368A2 Proteinfragmente die verschiedene epitope der hpv proteine e6 und e7 umfassen, ihre herstellung und verwendungen insbesondere zur impfung |
03/06/2002 | EP1183367A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy |
03/06/2002 | EP1183366A2 USE OF THE REGULATORY SUBUNIT OF THE CAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS |
03/06/2002 | EP1183365A1 Bacteriocin, preparation and use thereof |
03/06/2002 | EP1183364A1 Groel muteins with improved stability |
03/06/2002 | EP1183363A2 Methods for regulating protein conformation using molecular chaperones |
03/06/2002 | EP1183362A1 Il-1 eta dna and polypeptides |
03/06/2002 | EP1183361A1 Gene therapy of pulmonary disease |
03/06/2002 | EP1183360A2 Modified cytokine for its stabilisation |
03/06/2002 | EP1183359A2 Nucleic acids and proteins with interferon-beta activity |
03/06/2002 | EP1183358A1 Targeted angiogenesis |
03/06/2002 | EP1183357A2 Vascular endothelial growth factor dimers |
03/06/2002 | EP1183356A2 Gustatory receptors in drosophila |
03/06/2002 | EP1183355A1 T-bet compositions and methods of use thereof |
03/06/2002 | EP1183354A2 Methods of reducing factor viii clearance and compositions therefor |
03/06/2002 | EP1183353A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
03/06/2002 | EP1183352A1 Vascular endothelial growth factor variants |
03/06/2002 | EP1183351A1 Phospholipid transfer protein |
03/06/2002 | EP1183350A2 Expression products of genes involved in diseases related to cholesterol metabolism |
03/06/2002 | EP1183349A1 Tumor-associated antigen (c42) |
03/06/2002 | EP1183348A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
03/06/2002 | EP1183347A1 Interaction-activated proteins |
03/06/2002 | EP1183346A1 Method for generating split, non-transferable genes that are able to express an active protein product |
03/06/2002 | EP1183345A2 Directed evolution of microorganisms |
03/06/2002 | EP1183344A2 Adam polynucleotides and polypeptides |
03/06/2002 | EP1183338A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 97 and 98 |
03/06/2002 | EP1183332A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
03/06/2002 | EP1183331A2 Undifferentiated erythroid cells and their use in ligand binding assays |
03/06/2002 | EP1183330A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
03/06/2002 | EP1183329A2 Differentiated human embryoid cells and a method for producing them |
03/06/2002 | EP1183273A1 C-cam as an angiogenesis inhibitor |
03/06/2002 | EP1183272A2 49 human secreted proteins |
03/06/2002 | EP1183271A1 Polymer conjugates of hedgehog proteins and uses |
03/06/2002 | EP1183270A2 Novel organic anion transport proteins |
03/06/2002 | EP1183269A1 Attenuated microorganisms for the treatment of infection |
03/06/2002 | EP1183268A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
03/06/2002 | EP1183231A1 Cytofectin dimers and methods of use thereof |
03/06/2002 | EP1183102A1 The use of microfluidic systems in the electrochemical detection of target analytes |
03/06/2002 | EP1183049A2 Modification of biological elements |
03/06/2002 | EP1183040A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
03/06/2002 | EP1182929A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues |
03/06/2002 | EP1182924A2 TRANSGENIC MOUSE HAVING A LacZ REPORTER GENE UNDER THE CONTROL OF THE N-CAM PROMOTER USEFUL FOR IDENTIFYING N-CAM MODULATORS, METHODS AND COMPOSITIONS |
03/06/2002 | EP1123413A4 Multiple sequencing method |
03/06/2002 | EP1100889A4 Micellar systems |
03/06/2002 | EP1071811B1 A method for the characterisation of nucleic acid molecules involving generation of extendible upstream dna fragments resulting from the cleavage of nucleic acid at an abasic site |
03/06/2002 | EP1029076A4 Screening for novel compounds which regulate biological interactions |
03/06/2002 | EP1003534B1 Reovirus for the treatment of neoplasia |
03/06/2002 | EP0938505B1 Anti-endoglin monoclonal antibodies and their use in anti-angiogenesis therapy |
03/06/2002 | EP0910623A4 Thrombin receptor modified transgenic animals |
03/06/2002 | EP0848757B1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
03/06/2002 | EP0820516B1 Exopolysaccharide degrading enzyme and use of the same |
03/06/2002 | EP0736100B1 Recombinant protein production in bovine adenovirus expression vector system |
03/06/2002 | EP0726958B1 A new cephalosporin c acylase |
03/06/2002 | EP0722507B1 Detection of amplified or deleted chromosomal regions on human chromosome 20 |
03/06/2002 | EP0710110B1 Antibodies of ring opened rapamycins |
03/06/2002 | EP0694071B1 Adenovirus for the transfer of foreign dna into higher eucaryotic cells |
03/06/2002 | EP0672189B1 A method of processing nucleic acid samples |
03/06/2002 | EP0584201B1 Transmission-blocking vaccine against malaria |
03/06/2002 | CN1339107A Method of identifying N-terminal proBNP |
03/06/2002 | CN1339068A Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
03/06/2002 | CN1339067A Synthetic and chimeric promoters, expresion cassettes, plasmids, vectors, transgenic plants and seeds containing them, and method for producing them |
03/06/2002 | CN1339066A Alzheimer's disease secretase |
03/06/2002 | CN1339065A Method for preparing highly pure albumin solution |
03/06/2002 | CN1339064A Antibody binding to human airway trypsin-like enzyme and utilization thereof |
03/06/2002 | CN1339063A Human hybrid host cell for mammalian gene expression |
03/06/2002 | CN1338943A Use of VEGF-C or VEGF-D gene or protein to prevent resitenosis |
03/06/2002 | CN1338896A Method for increasing transgenic biomass |
03/06/2002 | CN1338517A Polypeptide-human dihydropteridine reductase 19.47 and polynucleotide for coding it |
03/06/2002 | CN1338516A Polypeptide-human prohormone and proteinogen convertase hPC135.97 and polynucleotide for coding it |
03/06/2002 | CN1338515A Refractory beta-glucosiduronatase gene and its obtaining process |
03/06/2002 | CN1338513A Recombinant adenovirus for preventing baby's diarrhea |
03/06/2002 | CN1338473A Fusion protein with angiogenesis suppression action |
03/06/2002 | CN1338472A Polypeptide-human zinc finger protein 75.68 and polynucleotide for coding it |